Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein

FEBS Letters
Mayuko OsadaYoshihiko Funae

Abstract

Apigenin, a plant-derived flavone, is a potent inhibitor of cell proliferation and angiogenesis, but the mechanisms leading to the pathological anti-angiogenic effects of apigenin are still unclear. In this study, we found that apigenin inhibited the hypoxia-induced expression of vascular endothelial growth factor (VEGF) mRNA in human umbilical artery endothelial cells. Apigenin also suppressed the expression of erythropoietin mRNA, which is a typical hypoxia-inducible gene, via the degradation of hypoxia-inducible factor 1 (HIF-1) alpha. We investigated the effect of apigenin on the interaction of HIF-1alpha with heat shock protein 90 (Hsp90), which is reported to be important for the stabilization of HIF-1alpha, and found that VEGF expression was inhibited via degradation of HIF-1alpha through interference with the function of Hsp90.

References

Apr 1, 1990·Archives of Biochemistry and Biophysics·S ImaokaY Funae
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T FotsisL Schweigerer
Jan 20, 1995·The Journal of Biological Chemistry·G L Wang, G L Semenza
Sep 1, 1996·Molecular and Cellular Biology·J A ForsytheG L Semenza
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Jan 10, 2002·The Journal of Biological Chemistry·Dorthe M KatschinskiRoland H Wenger
Feb 2, 2002·Science·David LandoMurray L Whitelaw
Apr 25, 2002·The Journal of Biological Chemistry·Mayuko OsadaYoshihiko Funae
Jun 11, 2002·Biochemical and Biophysical Research Communications·William J Wilson, Lorenz Poellinger
Dec 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert L StrausbergUNKNOWN Mammalian Gene Collection Program Team
Jan 9, 2003·The Journal of Biological Chemistry·Richard W D WelfordChristopher J Schofield

❮ Previous
Next ❯

Citations

Mar 24, 2007·Applied Microbiology and Biotechnology·Seiki TakenoMasato Ikeda
Apr 7, 2007·Cancer Metastasis Reviews·Giovanni Melillo
Mar 23, 2010·Pharmaceutical Research·Sanjeev Shukla, Sanjay Gupta
Aug 28, 2009·Expert Reviews in Molecular Medicine·Evon PoonMargaret Ashcroft
Jan 24, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yanhong Zou, George C Y Chiou
Mar 4, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Minoru TakahashiTakashi Sato
Jul 31, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Zhiyu WangJiangang Shen
Nov 2, 2014·Nature Reviews. Drug Discovery·Holger K EltzschigSean P Colgan
Jan 17, 2009·Journal of Cancer Research and Clinical Oncology·Yun Jung ChoiJae Cheol Lee
Mar 16, 2013·Clinical and Experimental Hypertension : CHE·Mirjana RadenkovićSuzana Branković
Jan 14, 2011·The Journal of Surgical Research·Laleh G MelstromDavid J Bentrem
Oct 16, 2007·Drug Discovery Today·Gregg L Semenza
Sep 3, 2005·Phytochemistry·Stefan Martens, Axel Mithöfer
Nov 19, 2015·Acta Pharmaceutica Sinica. B·Georgina N Masoud, Wei Li
Mar 22, 2006·Expert Opinion on Therapeutic Targets·Gregg L Semenza
Sep 9, 2008·Journal of Pharmacological Sciences·Sachiko SuzukiSusumu Imaoka
Feb 7, 2012·European Journal of Medicinal Chemistry·Yan XiaKyeong Lee
Aug 25, 2010·Pharmacology & Therapeutics·Gabriella LeonarduzziGiuseppe Poli
Nov 3, 2016·Expert Opinion on Drug Metabolism & Toxicology·Ding TangJuan Li
Mar 4, 2017·International Journal of Molecular Sciences·Eun-Ji ParkJi-Hong Lim
Nov 3, 2009·Drug Metabolism and Pharmacokinetics·Ami OguroSusumu Imaoka
Oct 19, 2006·Pharmacology & Therapeutics·KangAe LeeJohn J LaPres
Feb 23, 2017·International Journal of Biological Macromolecules·Morteza EskandaniYadollah Omidi
Jul 1, 2017·Critical Reviews in Food Science and Nutrition·Jairam K P VanamalaKenneth F Reardon
Feb 6, 2018·Current Pharmacology Reports·Eswar ShankarSanjay Gupta
Jan 10, 2019·Annual Review of Pharmacology and Toxicology·Gregg L Semenza
Dec 5, 2018·Reviews on Environmental Health·Lei Jiang, Hitoshi Iwahashi
Jun 16, 2005·International Journal of Cancer. Journal International Du Cancer·Denis MottetCarine Michiels
Apr 21, 2017·Oncotarget·Shuai MengLi-Ping Xie
Jun 21, 2020·Molecular and Cellular Biochemistry·Gowru SrivaniGanji Purnachandra Nagaraju
Dec 18, 2019·Bioorganic & Medicinal Chemistry·Wendi Tang, Guisen Zhao
Apr 20, 2020·Medical Hypotheses·Mark F McCartyLidianys Lewis Lujan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.